BACKGROUND: Substance-abusing adults are admitted to hospitals for medical complications from their drug and alcohol use at substantially higher rates than the general public; yet, their care is often defined by against medical advice (AMA) discharges and low rates of referral to addiction treatment programs. METHODS: We present findings from a chart review of consecutive admissions to an integrated medical-substance abuse treatment program designed for acutely ill, hospitalized substance using adults. We specifically looked at factors associated with program completion and medical complications in this cohort of at-risk adults. RESULTS: Overall, 83 patient cases were studied. The mean age was 41.2 years; most were African American (73.5%), male (68.7%), and homeless (77.1%). Heroin (96.4%) and cocaine (88.0%), followed by alcohol (44.6%) were the most commonly used substances before admission. The most common admitting diagnoses were infectious endocarditis (43.4%), abscess or nonhealing ulcer (18.1%), and osteomyelitis (13.3%) with intravenous antibiotic (68.7%), physical therapy (48.2%), or wound care (41.0%), the most commonly prescribed care on the integrated care/day hospital unit. The mean length of stay in the day hospital was 12.4 days. Overall, 69.9% of patients successfully completed their medical therapy, and 63.9% were successfully referred to an outpatient substance abuse treatment program. Only 10.8% required an unscheduled hospital readmission and 15.7% required an after-hours emergency department visit during their stay. CONCLUSION: Outpatient/day hospital-based integrated treatment is a viable option for medically ill substance-abusing adults who would otherwise be hospitalized and is associated with higher than expected completion rates and low rate of complications. Co-locating the unit at a hospital and integrating extensive social supports appear to be key components to this model.
BACKGROUND: Substance-abusing adults are admitted to hospitals for medical complications from their drug and alcohol use at substantially higher rates than the general public; yet, their care is often defined by against medical advice (AMA) discharges and low rates of referral to addiction treatment programs. METHODS: We present findings from a chart review of consecutive admissions to an integrated medical-substance abuse treatment program designed for acutely ill, hospitalized substance using adults. We specifically looked at factors associated with program completion and medical complications in this cohort of at-risk adults. RESULTS: Overall, 83 patient cases were studied. The mean age was 41.2 years; most were African American (73.5%), male (68.7%), and homeless (77.1%). Heroin (96.4%) and cocaine (88.0%), followed by alcohol (44.6%) were the most commonly used substances before admission. The most common admitting diagnoses were infectious endocarditis (43.4%), abscess or nonhealing ulcer (18.1%), and osteomyelitis (13.3%) with intravenous antibiotic (68.7%), physical therapy (48.2%), or wound care (41.0%), the most commonly prescribed care on the integrated care/day hospital unit. The mean length of stay in the day hospital was 12.4 days. Overall, 69.9% of patients successfully completed their medical therapy, and 63.9% were successfully referred to an outpatient substance abuse treatment program. Only 10.8% required an unscheduled hospital readmission and 15.7% required an after-hours emergency department visit during their stay. CONCLUSION:Outpatient/day hospital-based integrated treatment is a viable option for medically ill substance-abusing adults who would otherwise be hospitalized and is associated with higher than expected completion rates and low rate of complications. Co-locating the unit at a hospital and integrating extensive social supports appear to be key components to this model.
Authors: Courtney D Nordeck; Christopher Welsh; Robert P Schwartz; Shannon Gwin Mitchell; Art Cohen; Kevin E O'Grady; Jan Gryczynski Journal: Drug Alcohol Depend Date: 2018-03-02 Impact factor: 4.492
Authors: Christopher W Shanahan; Donna Beers; Daniel P Alford; Eileen Brigandi; Jeffrey H Samet Journal: J Gen Intern Med Date: 2010-03-17 Impact factor: 5.128
Authors: Adeline Nyamathi; Peggy Compton; Allan Cohen; Mary Marfisee; Steven Shoptaw; Barbara Greengold; Viviana de Castro; Mashid Reaves; Albert Hasson; Daniel George; Barbara Leake Journal: West J Nurs Res Date: 2009-01-07 Impact factor: 1.967
Authors: Paul Trowbridge; Zoe M Weinstein; Todd Kerensky; Payel Roy; Danny Regan; Jeffrey H Samet; Alexander Y Walley Journal: J Subst Abuse Treat Date: 2017-05-11
Authors: Rajvi Jayant Wani; Shinobu Watanabe-Galloway; Hyo Jung Tak; Li-Wu Chen; Nizar Wehbi; Fernando Wilson Journal: Evid Based Ment Health Date: 2020-01-06
Authors: Jennifer McNeely; Andrea B Troxel; Hillary V Kunins; Donna Shelley; Joshua D Lee; Alexander Walley; Zoe M Weinstein; John Billings; Nichola J Davis; Roopa Kalyanaraman Marcello; Bruce R Schackman; Charles Barron; Luke Bergmann Journal: Addict Sci Clin Pract Date: 2019-02-19